Structures by: Chernega A. N.
Total: 140
Co (H C O O)2 (H C O N H2)2
C4H4CoN2O6
Zeitschrift fuer Anorganische und Allgemeine Chemie (2002) 628, 51-56
a=12.7589Å b=8.25Å c=8.1893Å
α=90° β=92.643° γ=90°
Potassium salt of bis (N- (trifluoromethylsulfonylimino))trifluoro-methanesulfonic acid
C3F9K1N2O5S3
Organic & biomolecular chemistry (2005) 3, 12 2239-2243
a=22.385(6)Å b=16.653(4)Å c=7.093(4)Å
α=90° β=90° γ=90°
Potassium solt of N-bis(N- (trifluoromethylsulfonylimido))trifluoromethane-sulfoximidoyl imide
C4F12K1N3O6S4
Organic & biomolecular chemistry (2005) 3, 12 2239-2243
a=13.479(7)Å b=11.203(4)Å c=24.545(8)Å
α=90° β=90° γ=90°
Copper(I) Tetrafluoroborate 4:5 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 4 Chloroform
C74H54B4Cl12Cu4F16N20
New Journal of Chemistry (2008) 32, 11 1910
a=12.5703(9)Å b=13.7895(13)Å c=14.1629(12)Å
α=94.203(11)° β=93.205(11)° γ=107.835(10)°
Copper(I) Dithionate bis(Acetonitrile) complex with 1,4-bi(pyridazin-4-yl)benzene
C18H16Cu2N6O6S2
New Journal of Chemistry (2008) 32, 11 1910
a=9.3471(6)Å b=18.9283(11)Å c=12.4791(9)Å
α=90.00° β=101.718(8)° γ=90.00°
Silver(I) nitrate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Chloroform solvate
C15H11AgCl3N5O3
New Journal of Chemistry (2008) 32, 11 1910
a=8.3964(2)Å b=9.5399(2)Å c=12.4383(3)Å
α=80.0473(10)° β=82.901(2)° γ=64.9520(11)°
Silver(I) Pentafluoropropionate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene
C17H10AgF5N4O2
New Journal of Chemistry (2008) 32, 11 1910
a=5.5566(7)Å b=10.5875(13)Å c=15.419(2)Å
α=72.987(10)° β=84.721(11)° γ=82.058(11)°
Silver(I) Methanesulfonate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 2 Chloroform
C48H44Ag4Cl6N12O12S4
New Journal of Chemistry (2008) 32, 11 1910
a=19.3101(19)Å b=17.3714(15)Å c=18.1903(15)Å
α=90.00° β=99.346(5)° γ=90.00°
Silver(I) Benzoate 2:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C28H24Ag2N4O6
New Journal of Chemistry (2008) 32, 11 1910
a=7.2863(3)Å b=14.3867(6)Å c=12.2774(5)Å
α=90.00° β=90.945(3)° γ=90.00°
Silver(I) Isophthalate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C66H62Ag6N12O22
New Journal of Chemistry (2008) 32, 11 1910
a=9.4238(6)Å b=14.2038(12)Å c=14.2032(10)Å
α=104.457(8)° β=98.140(8)° γ=108.924(9)°
Tetrakis(3,3',5,5'-tetramethyl-4,4'-bipyrazolyl) Sulfato Diperchlorato Dicobalt(II), trihydrate
C40H62Cl2Co2N15O16S
Chemical Communications (2002) 5 436
a=13.7588(9)Å b=13.7588(9)Å c=16.7261(14)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl) Sulfato Dinitrato Dinickel(II), trihydrate
C40H62N18Ni2O13S
Chemical Communications (2002) 5 436
a=13.6542(13)Å b=13.6542(13)Å c=16.477(2)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-Tetramethyl-4,4'-Bipyrazolyl) Sulfato Bis(thiocyanato) Dicobalt(II), Bis(Methanol) Bis(Chloroform) Solvate
C46H66Cl6Co2N18O6S3
Chemical Communications (2002) 5 436
a=13.699(2)Å b=21.594(3)Å c=22.220(3)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl) Sulfato Bis(thiocyanato) Dinickel(II), Bis(methanol) Bis(chloroform) Solvate
C46H66Cl6N18Ni2O6S3
Chemical Communications (2002) 5 436
a=13.6250(14)Å b=21.376(2)Å c=22.072(2)Å
α=90.00° β=90.00° γ=90.00°
1,4-bis(2-(1-ethyl-pyridinium-4-yl)vinyl)benzene di-4- methylbenzenesulphonate
C38H40N2O6S2
CrystEngComm (2011) 13, 5 1373
a=13.279(2)Å b=17.696(3)Å c=14.791(2)Å
α=90° β=101.907(4)° γ=90°
1,4-bis(2-(1-methyl-pyridinium-4-yl)vinyl)benzene di-4- methylbenzenesulphonate - methanol (2:1)
C37H40N2O7S2
CrystEngComm (2011) 13, 5 1373
a=10.9786(3)Å b=12.2743(4)Å c=14.0937(4)Å
α=88.107(2)° β=87.121(2)° γ=63.853(2)°
1,4-bis(2-(1-methyl-pyridinium-4-yl)vinyl)benzene di-4- methylbenzenesulphonate
C36H36N2O6S2
CrystEngComm (2011) 13, 5 1373
a=10.806(2)Å b=12.627(3)Å c=13.592(3)Å
α=90.359(9)° β=93.936(8)° γ=114.693(7)°
1,4-bis(2-(1-ethyl-pyridinium-4-yl)vinyl)benzene di-4- methylbenzenesulphonate tetrahydrate
C38H48N2O10S2
CrystEngComm (2011) 13, 5 1373
a=9.191(2)Å b=9.3575(19)Å c=12.722(3)Å
α=102.463(18)° β=91.268(19)° γ=113.860(16)°
1,4-bis(2-(1-(2-amino-2-oxoethyl)-pyridinium-4-yl)vinyl)benzene dichloride
C24H34Cl2N4O7
CrystEngComm (2011) 13, 5 1373
a=19.0114(11)Å b=4.9005(4)Å c=31.062(2)Å
α=90° β=103.635(5)° γ=90°
1,4-bis(2-(1-methyl-pyridinium-4-yl)vinyl)benzene di-4- methylbenzenesulphonate dihydrate
C36H40N2O7S2
CrystEngComm (2011) 13, 5 1373
a=8.9032(11)Å b=18.990(2)Å c=9.9994(11)Å
α=90° β=92.093(5)° γ=90°
Copper(ii) Fluorophosphate 1:3 Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene
C30H24CuN18,(FO3P)
CrystEngComm (2008) 10, 9 1216
a=16.0657(11)Å b=16.0657(11)Å c=7.7720(4)Å
α=90.00° β=90.00° γ=120.00°
Copper(ii) Nitrate 2:5 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dihydrate
C50H40Cu2N30,4(NO3),2(H2O)
CrystEngComm (2008) 10, 9 1216
a=24.6600(18)Å b=15.8459(8)Å c=7.7808(5)Å
α=90.00° β=95.485(8)° γ=90.00°
Copper(ii) Chloride 1:2 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dodecahydrate
C20H40Cl2CuN12O12
CrystEngComm (2008) 10, 9 1216
a=28.331(3)Å b=16.1470(12)Å c=7.1760(9)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Bromide 1:2 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dodecahydrate
(C20H16BrCuN12),Br,12(H2O)
CrystEngComm (2008) 10, 9 1216
a=28.449(3)Å b=15.7732(17)Å c=7.2593(7)Å
α=90.00° β=90.00° γ=90.00°
Dihydroxo Tetracopper(ii) Triflate Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene, Dodecahydrate
C56H66Cu4F18N30O32S6
CrystEngComm (2008) 10, 9 1216
a=13.3427(11)Å b=13.4047(12)Å c=13.5620(12)Å
α=102.339(2)° β=104.3690(10)° γ=90.4770(10)°
Copper(ii) Sulfate Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Hexahydrate
C10H20CuN6O10S
CrystEngComm (2008) 10, 9 1216
a=7.1442(4)Å b=19.4387(15)Å c=17.3114(12)Å
α=90.00° β=90.00° γ=90.00°
Tris(5-(4-(1,2,4-triazol-4-yl)phenyl)tetrazolato) dicopper(ii) Chloride, Dodecahydrate
C27H42ClCu2N21O12
CrystEngComm (2008) 10, 9 1216
a=25.822(2)Å b=7.7119(7)Å c=25.1892(19)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 4:5 Complex with Pyridazino(4,5- d)pyridazine
(C30H20Ag4N20),4(ClO4)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0076(10)Å b=17.0076(10)Å c=7.8591(5)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Hexaflurosilicate Tetrafluoroborate Complex with Pyridazino(4,5-d)pyridazine Hydrate
2(C15H10Ag2N10),F6Si,2(BF4),4(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0801(11)Å b=17.0782(11)Å c=7.5920(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(NO3)
Dalton Transactions (2009) 15 2856-2864
a=7.7351(7)Å b=10.8172(8)Å c=7.1540(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(ClO4)
Dalton Transactions (2009) 15 2856-2864
a=8.4650(7)Å b=10.4250(11)Å c=7.7750(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
(C4H6N4),2Ag,2(NO3)
Dalton Transactions (2009) 15 2856-2864
a=9.0359(8)Å b=13.2071(13)Å c=8.7513(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine, Dihydrate
(C4H6N4),2Ag,2(ClO4),2(H2O)
Dalton Transactions (2009) 15 2856-2864
a=6.7481(8)Å b=7.9981(9)Å c=8.1382(10)Å
α=65.302(11)° β=65.663(10)° γ=66.151(11)°
Copper(i) chloride 4:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
C4H6N4,4(CuCl)
Dalton Transactions (2009) 15 2856-2864
a=6.8143(9)Å b=6.2582(8)Å c=13.6220(17)Å
α=90.00° β=98.907(4)° γ=90.00°
Silver(i) Triflate 3:1 complex with 2,6-dimethyl-1,2,4,5- tetrazine, dihydrate
2(C4H6N4),6Ag,6(CF3O3S),4(H2O)
Dalton Transactions (2009) 15 2856-2864
a=10.5847(9)Å b=19.0579(13)Å c=23.1327(14)Å
α=90.00° β=102.038(10)° γ=90.00°
Copper(ii) acetate 2:1 complex with 4,4'-Bipyridazine, Dihydrate
C8H9CuN2O4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=7.4144(9)Å b=8.2275(9)Å c=10.9023(13)Å
α=76.965(14)° β=82.505(13)° γ=63.267(13)°
Zinc(ii) Nitrate 1:1 Complex with 4,4'-Bipyridazine
C8H6N6O6Zn
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.07500(10)Å b=16.9431(3)Å c=11.9592(2)Å
α=90.00° β=101.3800(10)° γ=90.00°
Copper(ii) Dithionate 1:2 Complex with 4,4'-Bipyridazine, Dihydrate
C16H16CuN8O2,O6S2
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.1065(13)Å b=11.8885(9)Å c=11.0631(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Trifluoroacetate 2:3 Complex with 4,4'-Bipyridazine
C32H18CU2F12N12O8
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.4940(6)Å b=10.9798(8)Å c=18.3058(13)Å
α=90.00° β=98.572(5)° γ=90.00°
Copper(ii) Tetrafluoroborate 1:2 Complex with 4,4'- Bipyridazine, Solvate with 3.33 Water
C48H36Cu3N24O4,6(BF4),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=12.0861(8)Å b=14.6555(8)Å c=21.5673(15)Å
α=90.00° β=104.025(8)° γ=90.00°
Dihydroxotricopper(ii) Trifluoroacetate Complex with 4,4'- Bipyridazine, Tetrahydrate
(C28H24Cu3F6N12O8),2(C2F3O2),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.4234(9)Å b=15.7761(12)Å c=19.1034(12)Å
α=90.00° β=108.591(6)° γ=90.00°
Copper(i) Chloride 2:1 Complex with 4,4'-Bipyridazine
C8H6CL2CU2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.617(2)Å b=13.132(4)Å c=6.642(2)Å
α=90.00° β=114.23(2)° γ=90.00°
Copper(i) Bromide 2:1 Complex with 4,4'-Bipyridazine
C8H6Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.712(2)Å b=13.450(4)Å c=6.807(3)Å
α=90.00° β=112.79(3)° γ=90.00°
Copper(i) Iodide 2:1 Complex with 4,4'-Bipyridazine
C8H6Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.1405(5)Å b=10.1405(5)Å c=11.9784(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Hexafluorosilicate 2:3 Complex with Pyridazino(4,5- d)pyridazine, Decahydrate
C18H20Ag4N12O4,2(F6Si),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.85070(10)Å b=17.2093(3)Å c=12.0859(2)Å
α=90.00° β=100.7850(10)° γ=90.00°
Silver(i) Trifluoroacetate Complex with Pyridazino(4,5- d)pyridazine
C8H4AgF3N4O2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.3514(2)Å b=12.5897(3)Å c=11.3054(3)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Pentafluoropropionate 2:1 Complex with Pyridazino(4,5-d)pyridazine
C12H4Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=25.2810(10)Å b=25.2810(10)Å c=7.4007(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexafluorosilicate 2:3 Complex with 4,4'- Bipyridazine, Trihydrate
C24H22Ag4N12O2,2(F6Si),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.7384(2)Å b=38.1690(8)Å c=50.8067(10)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Tetrafluoroborate 4:3 Complex with 4,4'- Bipyridazine Hydrate
(C24H18Ag4N12),4(BF4),(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=10.6823(8)Å b=12.1323(7)Å c=14.6844(9)Å
α=90.00° β=97.017(8)° γ=90.00°
Silver(i) Trifluoromethylsulfonate Complex with 4,4'- Bipyridazine, Solvate with 2/3 Water
C24H20Ag3N12O,3(CF3O3S),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.7652(6)Å b=22.1004(15)Å c=10.4417(7)Å
α=90.00° β=91.8740(10)° γ=90.00°
Silver(i) Pentafluoropropionate 2:1 Complex with 4,4'- Bipyridazine
C14H6Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=26.9862(12)Å b=26.9862(12)Å c=7.6176(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Trifluoroacetate 2:1 Complex with 4,4'- Bipyridazine, Solvate with 2/7 Chloroform
C84H42Ag14F42N28O28,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=13.9023(2)Å b=14.4405(3)Å c=18.2666(2)Å
α=107.0790(10)° β=111.5920(10)° γ=94.2320(10)°
Silver(I) Trifluoroacetate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, Acetonitrile solvate
C52H33Ag4F12N13O8
New Journal of Chemistry (2008) 32, 11 1910
a=10.9059(10)Å b=11.1531(11)Å c=13.8012(13)Å
α=92.620(11)° β=108.916(11)° γ=117.522(10)°
Dihydroxo Tricopper(ii) Sulfate Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene, Dihydrate
C10H14Cu3N6O12S2
CrystEngComm (2008) 10, 9 1216
a=5.1275(4)Å b=16.3726(11)Å c=10.8005(9)Å
α=90.00° β=99.531(10)° γ=90.00°
Silver(i) Trifluorometanesulfonate Complex with Pyridazino(4,5-d)pyridazine, Solvate with 0.33 Water
C18H14Ag3N12O,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=15.6887(9)Å b=15.6887(9)Å c=24.4805(18)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Heptafluorobutyrate 2:1 Complex with 4,4'- Bipyridazine
C16H6Ag2F14N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=28.4273(11)Å b=28.4273(11)Å c=7.5353(3)Å
α=90.00° β=90.00° γ=120.00°
Cobalt(I) Chloride 1:2 Complex with Beryllium 3-(4-Pyridyl)-2,4-pentanedionate, monohydrate
C40H42Be2Cl2CoN4O9
Dalton Transactions (2003) 9 1707
a=27.473(2)Å b=11.2165(5)Å c=13.7859(10)Å
α=90.00° β=103.000(8)° γ=90.00°
Beryllium 3-(4-Pyridyl)-2,4-pentanedionate, Methanol Solvate
C21H24BeN2O5
Dalton Transactions (2003) 9 1707
a=9.6272(3)Å b=10.6028(3)Å c=11.3100(5)Å
α=94.020(2)° β=114.8270(10)° γ=102.1680(10)°
Copper(I) Bromide Complex with Beryllium 3-(Pyridyl-4)-2,4-Pentanedionate, Solvate with Chloroform
C45.33H45.33Be2Br2Cl16Cu2N4O8
Dalton Transactions (2003) 9 1707
a=21.0193(9)Å b=25.1798(11)Å c=21.7707(9)Å
α=90.00° β=118.6180(10)° γ=90.00°
Cobalt(II) Acetate Benzoate 3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl, bis(Bromobenzene) clathrate
C31H32Br2CoN4O4
Journal of the Chemical Society, Dalton Transactions (2001) 6 893
a=14.1437(10)Å b=14.4751(11)Å c=16.4467(12)Å
α=90.00° β=97.7330(10)° γ=90.00°
Cobalt(II) Benzoate bis(3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl), bis(Bromobenzene) clathrate
C46H48Br2CoN8O4
Journal of the Chemical Society, Dalton Transactions (2001) 6 893
a=22.3175(7)Å b=22.3175(7)Å c=21.0429(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Nitrate 1:2 Complex with 1,2,3,6,7,8-hexahydro- cinnolino(5,4,3-cde)cinnoline, Chloroform solvate
C27H27Cl9CuN10O6
Dalton transactions (Cambridge, England : 2003) (2004) 5 695-696
a=23.5623(10)Å b=23.5623(10)Å c=23.5623(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Perchlorate 1:2 Complex with 1,2,3,6,7,8-hexahydro- cinnolino(5,4,3-cde)cinnoline, Chloroform solvate
C27H27Cl11CuN8O8
Dalton transactions (Cambridge, England : 2003) (2004) 5 695-696
a=23.7035(14)Å b=23.7035(14)Å c=23.7035(14)Å
α=90.00° β=90.00° γ=90.00°
Bis-[1,3-di(1,2,4-triazol-4-yl)adamantane]diaquacadmium(II) Tetrabromocadmate(II) Dihydrate
C56H80Cd2N24O4,2(Br4Cd),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=14.7635(12)Å b=29.457(3)Å c=17.5708(16)Å
α=90.00° β=90.031(8)° γ=90.00°
Bis-(1,3,5-tri(1,2,4-triazol-4-yl)adamantane)cadmium(ii) Nitrate Hexahydrate
(C32H38CdN18),2(NO3),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=11.5603(2)Å b=11.5603(2)Å c=53.0233(19)Å
α=90.00° β=90.00° γ=120.00°
Tetrakis-[1,3-di(1,2,4-triazol-4-yl)adamantane]cadmium(II) bis-triiodocadmate(II) Tetrahydrate
C56H72Cd3I6N24,4(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=10.3397(2)Å b=11.3871(2)Å c=17.8908(5)Å
α=95.6320(10)° β=102.9610(10)° γ=115.4300(10)°
Bis-(1,3-di(1,2,4-triazol-4-yl)adamantane)disilver(i) dinitrate Dihydrate
C28H36Ag2N12,2(NO3),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=6.5192(6)Å b=15.4818(11)Å c=16.9913(12)Å
α=89.230(9)° β=84.607(10)° γ=85.574(9)°
Bis-[1,3,5-tri(1,2,4-triazol-4-yl)adamantane]cadmium(II) Tetrachlorocadmate(II) Trihydrate
(C32H38CdN18),(CdCl4),3(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=11.3552(11)Å b=11.3552(11)Å c=54.979(3)Å
α=90.00° β=90.00° γ=120.00°
Bis-[3,5,7-tri(1,2,4-triazol-4-yl)-1-azaadamantane]cadmium(II) Tetraiodocadmate(II) Trihydrate
(C30H36CdN20),(CdI4),3(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=11.4936(8)Å b=11.4936(8)Å c=57.216(2)Å
α=90.00° β=90.00° γ=120.00°
Bis-[3,5,7-tri(1,2,4-triazol-4-yl)-1-azaadamantane]-dihydroxy-tetraaqua- tricopper(II) Perchlorate
C30H46Cl2Cu3N20O14,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=12.1931(7)Å b=17.2484(12)Å c=22.1135(11)Å
α=90.00° β=90.00° γ=90.00°
Bis-[3,5,7-tri(1,2,4-triazol-4-yl)-1-azaadamantane]-triaqua- dicopper(II) Sulfate Heptahydrate
C30H42Cu2N20O3,2(O4S),7(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=21.8567(15)Å b=11.5525(9)Å c=21.4604(14)Å
α=90.00° β=117.611(4)° γ=90.00°
Tris-[3,5,7-tri(1,2,4-triazol-4-yl)-1-azaadamantane]- dicadmium(II) Chloride Octacosahydrate
C45H54Cd2N30,28(H2O),Cl4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=18.5633(17)Å b=18.5633(17)Å c=14.3967(13)Å
α=90.00° β=90.00° γ=120.00°
(1,3,5,7-tetrakis(1,2,4-triazol-4- yl)adamantane)aquacopper(ii) Perchlorate Trihydrate
C18H22CuN12O,2(ClO4),3(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=17.1623(13)Å b=13.1560(8)Å c=12.8631(8)Å
α=90.00° β=90.00° γ=90.00°
Bis-[1,3,5,7-tetra(1,2,4-triazol-4-yl)adamantane]-hexachloro- tricadmium(II) Nonahydrate
C36H40Cd3Cl6N24,9(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=28.2333(5)Å b=8.7809(2)Å c=11.3833(2)Å
α=90.00° β=90.00° γ=90.00°
[1,3,5,7-tetrakis(1,2,4-triazol-4-yl)adamantane]silver(I) Nitrate, Solvate with 3.5 Water
(C18H20AgN12),(NO3),3.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=11.9308(12)Å b=18.9239(12)Å c=22.4189(15)Å
α=90.00° β=90.00° γ=90.00°
1,2,6,6a,7,8,14,14a-octahydrobenzo[f]naphtho[2,1-c]cinnoline- 9,12(5H,13H)-dihydrazone, Solvate with Ethanol and Water
2(C20H24N6),C2H6O,H2O
Chem.Commun. (2012) 48, 5847
a=10.7110(10)Å b=11.5603(11)Å c=18.6159(16)Å
α=76.538(6)° β=90.023(6)° γ=62.401(7)°
1,2,6,6a,7,7a,8,9,17,17a,18,18a-dodecahydroanthra[2,1-c]naphtho- [2,3-f]cinnoline-10,15(5H,16H)-dihydrazone, Ethanol solvate
C28H32N6,C2H6O
Chem.Commun. (2012) 48, 5847
a=17.8207(6)Å b=6.1397(2)Å c=24.7531(8)Å
α=90.00° β=100.4510(10)° γ=90.00°
3,4,4a,5,6,9,10,10a,11,12-decahydroanthra [1,9,8-cdef:5,10,4-cdef]dicinnoline, Dihydrate
C20H18N4,2(H2O)
Chem.Commun. (2012) 48, 5847
a=5.0227(5)Å b=13.5312(14)Å c=12.4146(15)Å
α=90.00° β=94.498(8)° γ=90.00°
(3,4,4a,5,6,9,10,10a,11,12-decahydroanthra [1,9,8-cdef:5,10,4-cdef]dicinnoline)diiododicopper(I), Solvate with Acetonitrile and Chloroform
(C20H18Cu2I2N4),CHCl3,C2H3N
Chem.Commun. (2012) 48, 5847
a=22.3792(2)Å b=22.3792(2)Å c=13.1261(3)Å
α=90.00° β=90.00° γ=90.00°
(3,4,4a,5,6,9,10,10a,11,12-decahydroanthra [1,9,8-cdef:5,10,4-cdef]dicinnoline)dichlorodicopper(I), Solvate with 4 Acetonitrile
C20H18Cl2Cu2N4,4(C2H3N)
Chem.Commun. (2012) 48, 5847
a=15.9327(9)Å b=15.9327(9)Å c=12.4522(10)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) hexafluorosilicate, solvate with 3 methanol
C58H48Cu2F6N16O2Si,F6Si,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.1490(3)Å b=17.1490(3)Å c=20.7268(9)Å
α=90.00° β=90.00° γ=90.00°
Μ-[Hexafluorosilicato/Hexafluorogermanato 0.89:0.11]- tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorogermanate 0.38:0.62, solvate with 3 methanol
C58H48Cu2F6Ge0.11N16O2Si0.89,F6Ge0.62Si0.38,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.2531(3)Å b=17.2531(3)Å c=20.5377(10)Å
α=90.00° β=90.00° γ=90.00°
Μ-[Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorostannate(IV) 0.21:0.79, solvate with 3 methanol
C58H48Cu2F6N16O2Si,F6Si0.21Sn0.79,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.3756(4)Å b=17.3756(4)Å c=20.5964(9)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-diaquadicopper(II) bis-hexafluorophosphate, solvate with 4 chloroform
C56H44Cu2F6N16O2Si,2(F6P),4(CHCl3)
Chem.Commun. (2013) 49, 9018
a=12.6120(9)Å b=12.6185(7)Å c=25.342(2)Å
α=90.00° β=99.262(9)° γ=90.00°
Μ-[Hexafluorosilicato/Hexafluorogermanate 0.93:0.07]- tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorogermanate 0.67:0.33, solvate with 3 methanol
C58H48Cu2F6Ge0.07N16O2Si0.93,F6Ge0.33Si0.67,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.1776(8)Å b=17.1776(8)Å c=20.715(2)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorostannate(IV) 0.50:0.50, solvate with 3 methanol
C58H48Cu2F6N16O2Si,F6Si0.50Sn0.50,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.2903(3)Å b=17.2903(3)Å c=20.5440(10)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-aqua-methanoldicopper(II) bis-perchlorate, solvate with 5.5 chloroform
2(C57H46Cu2F6N16O2Si),4(ClO4),11(CHCl3)
Chem.Commun. (2013) 49, 9018
a=12.8708(6)Å b=12.5785(5)Å c=50.263(2)Å
α=90.00° β=93.272(3)° γ=90.00°
N-(2-aminoethyl)piperaziniumtetrachloroindium(III)
C6H16In1Cl4N3
Acta Crystallographica Section C (1996) 52, 9 2180-2183
a=7.326(1)Å b=12.868(1)Å c=14.098(1)Å
α=90.000° β=94.49(1)° γ=90.000°
Diaquabis[4-(4H-1,2,4-triazol-4-yl)benzoato-κ^2^O,O]copper(II)
C18H16CuN6O6
Acta Crystallographica Section C (2007) 63, 4 m140-m143
a=13.4483(4)Å b=10.0101(3)Å c=14.4749(5)Å
α=90.00° β=111.674(2)° γ=90.00°
Diaquabis[4-(4H-1,2,4-triazol-4-yl)benzoato-κ^2^O,O]cadmium(II)
C18H16CdN6O6
Acta Crystallographica Section C (2007) 63, 4 m140-m143
a=13.7301(6)Å b=9.8915(5)Å c=14.8111(10)Å
α=90.00° β=112.063(3)° γ=90.00°
Poly[[aqua-μ~4~-pyridazino[4,5-d]pyridazine-μ~3~-sulfato-disilver(I)] monohydrate]
C6H6Ag2N4O5S,H2O
Acta Crystallographica Section C (2007) 63, 6 m259-m263
a=8.3733(2)Å b=8.7790(2)Å c=8.9006(3)Å
α=85.9270(10)° β=74.334(2)° γ=68.8160(10)°
Poly[[μ~4~-4,4-bipyridazine-μ~5~-sulfato-disilver(I)] monohydrate]
C8H6Ag2N4O4S,H2O
Acta Crystallographica Section C (2007) 63, 6 m259-m263
a=7.4829(9)Å b=8.4881(10)Å c=10.9267(10)Å
α=67.172(9)° β=88.971(8)° γ=67.092(8)°
4,4'-(<i>p</i>-phenylene)bipyridazine
C14H10N4
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=6.3588(7)Å b=6.9307(9)Å c=7.0681(10)Å
α=110.282(3)° β=90.823(3)° γ=106.585(2)°
Catena-poly[[dibromidocopper(II)]-μ~2~-4,4-(<i>p</i>-phenylene)bipyridazine- κ^2^N^2^:N^2'^]
C14H10Br2CuN4
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=4.1377(2)Å b=12.5407(7)Å c=13.5301(8)Å
α=90.00° β=93.786(4)° γ=90.00°
Catena-poly[[[tetrakis(μ-acetato-κ^2^<i>O</i>:<i>O</i>)dicopper(II)]- μ~2~-4,4'-(<i>p</i>-phenylene)bipyridazine-κ^2^N^1^:N^1'^] chloroform disolvate]
C22H22Cu2N4O8,2(CHCl3)
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=7.6349(8)Å b=8.0203(8)Å c=13.9312(10)Å
α=104.601(2)° β=103.993(2)° γ=90.123(3)°
1,3,5-Triphenyladamantane
C28H28
Acta Crystallographica Section C (2009) 65, 5 o248-o252
a=13.0230(4)Å b=13.0230(4)Å c=19.8046(13)Å
α=90.00° β=90.00° γ=120.00°
Poly[[bis(μ-4,4-bi-1<i>H</i>-pyrazole-κ^2^<i>N</i>^2^:<i>N</i>^2'^)bis(3-carboxyadamantane-1-carboxylato-κ<i>O</i>^1^)cobalt(II)] dihydrate]
C36H42CoN8O8,2(H2O)
Acta Crystallographica Section C (2013) 69, 3 232-236
a=10.0002(9)Å b=10.1568(8)Å c=10.2186(8)Å
α=89.906(6)° β=66.363(5)° γ=75.805(5)°
Poly[[bis(μ-4,4-bi-1<i>H</i>-pyrazole-κ^2^<i>N</i>^2^:<i>N</i>^2'^)bis(3-carboxyadamantane-1-carboxylato-κ<i>O</i>^1^)cadmium(II)] dihydrate]
C36H42CdN8O8,2(H2O)
Acta Crystallographica Section C (2013) 69, 3 232-236
a=14.5363(12)Å b=14.9862(13)Å c=18.3813(17)Å
α=90.00° β=105.384(7)° γ=90.00°
Poly[[diaquabis[μ~2~-3,3-bis(1,2,4-triazol-4-yl)-1,1'-biadamantane- κ^2^<i>N</i>^1^:<i>N</i>^1^']cadmium(II)] dithiocyanate dihydrate],
C48H68CdN12O22,2CNS,2H2O
Acta Crystallographica Section C (2010) 66, 7 m180-m183
a=6.8689(4)Å b=20.3896(12)Å c=18.3330(11)Å
α=90.00° β=99.242(2)° γ=90.00°
Poly[[diaquabis[μ~2~-3,3-bis(1,2,4-triazol-4-yl)-1,1'-biadamantane- κ^2^<i>N</i>^1^:<i>N</i>^1^']cadmium(II)] diselenocyanate dihydrate],
C48H68CdN12O22,2CNSe,2H2O
Acta Crystallographica Section C (2010) 66, 7 m180-m183
a=6.9147(5)Å b=20.4704(14)Å c=18.4190(15)Å
α=90.00° β=100.168(2)° γ=90.00°